Clinical Trials Directory

Trials / Suspended

SuspendedNCT04896827

DNIC Using Deep Learning and Artificial Intelligence

Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) Using Deep Learning and Artificial Intelligence

Status
Suspended
Phase
Study type
Observational
Enrollment
244 (estimated)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs. This study aims more specifically to determine whether it is possible to develop a facial recognition system to automate pain measurement and the effectiveness of pain control mechanisms.

Detailed description

This study aims: 1. To develop and validate a predictive tool (using deep learning and artificial intelligence) to estimate the efficacy of pain control mechanisms. 2. To estimate references values for facial expressions of pain control mechanisms in healthy and in chronic pain participants. The target population will be healthy volunteers and volunteers with chronic pain, male and female, stratified by age. The reference values (healthy volunteers) will be established via a non-parametric method for a standard conditioned pain modulation (CPM) protocol in which two "stimuli tests" of the same intensity and nature (heat) will be applied before and after the application of another "conditioning stimulus" (cold water bath). The perceived pain difference between the 1st and 2nd stimuli tests will reflect the intensity of the DNICs. Participants' facial expressions will be captured simultaneously by three cameras during the CPM testing. These results will be compared to those from volunteers suffering with chronic pain. The clinical decision rule will result from clinical and paraclinical elements correlating with the amplitude of the efficacy of CPM (serum noradrenaline, intensity of pain, heart rate and blood pressure measurements, psychometric questionnaires assessing anxiety, depressive feelings and pain catastrophizing). Logistic regression analysis will determine the best predictors of a CPM deficit.

Conditions

Interventions

TypeNameDescription
OTHERConditioned pain modulation testConditioned pain modulation (CPM) protocol consist of evaluating pain during a heat test, before and after one conditioning stimulus (cold water bath); 3 cameras will be capturing participants' facial expressions during the tests.

Timeline

Start date
2022-04-05
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2021-05-21
Last updated
2024-12-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04896827. Inclusion in this directory is not an endorsement.